https://www.bryair.com/media_coverage/building-capabilities-in-the-innovation-space/
=
Building capabilities in the innovation space | Bryair
BryairMedia CoverageBuilding capabilities in the innovation space

Building capabilities in the innovation space

Deepak Pahwa, Chairman, Pahwa Group and Managing Director, Bry-Air | Express Pharma Magazine | November 09, 2021

Deepak Pahwa

Managing Director, Bry-Air & Chairman, Pahwa Group

Over the last decade, innovation in healthcare and pharmaceutical has grown steadily. Innovation is considered to be an important pillar to the pharmaceutical industry. The fast pace of technological advances has been driving the growth of the sector. With the potential advancements in hi-tech space, the industry is paving the way for a more cost-effective, energy-efficient, reliable and most importantly, compliant to International Standards manufacturing facilities in the field of medicine and healthcare across the globe.

Technologies such as, mobile communications, the cloud, advanced analytics, and the Internet of Things are among the innovations that are playing a key role in transforming the healthcare industry. India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. The figure explains, how Indian pharmaceutical companies play a crucial role worldwide.

With such innovations, digitization is not only providing opportunities to improve efficiencies but playing a catalyst in taping new businesses and building effective relationships between patients and doctors.

The way Indian pharma market is going through rapid transformation, Pharma executives are well aware of the disruptive potential and are experimenting with a wide range of digital initiatives. Companies are quite aware of the fact that without the help of technology, the business can’t succeed. Hence, digital technology will drive the most value in the pharmaceutical industry.

According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and is likely to reach US$ 65 billion by 2024.

It is anticipated that by 2021, the global pharmaceutical sector will touch down $1170 Billion worth, with an impressive growth rate of 5.8%. To achieve the momentum, companies need to set up the right environment for collaborative experimentation. The pharmaceutical industry needs to work on several factors such as investing in modern machines, upgraded diagnostic kits, manufacturing of medicines and proper use of data science. All these measures will lead to a successful outcome.

However, to thrive in a digital world, pharma companies will need to take advantage of next-generation technologies to streamline their business processes in the near future to stay ahead of the curve. They need to keep upgrading at every possible step to cater to this huge demand, at the same time reliability and consistency is key factor in the health industry. Smart equipment needs smart devices to maintain efficacy and reliability. We at Bry-Air understand the industry requirements and the need for developing innovative solutions.

In the last few years, businesses went through a transformation while exploring new technologies to make India future-ready as well as Self-Reliant. Believing in the same proposition, we launched our Bry-Air BrySmart® Series (BBS) Dehumidifiers that are embedded with patented* BrySmart® and BryTherm™ technologies.

Bry-Air BrySmart® Series (BBS) Dehumidifiers

These dehumidifiers integrate industry 4.0 based concepts that reduce annual energy consumption by up to 48%. The BBS modulates various critical components to optimize energy consumption continuously leading to less energy consumption thus making it a cost-effective solution. Therefore, the advanced Dehumidifier is a step forward in energy conservation through enhanced automation. The Bry-Air BrySmart (BBS) Dehumidifier series is the latest offering catering to the new age requirement of energy-efficient moisture control solutions, providing quicker ROI and the lowest cost of ownership.

Moreover, we have Desiccant Dehumidification, one of the most effective techniques to protect pharmaceutical raw material and products during processing, storage and packaging from moisture menace. Bry-Air desiccant dehumidifiers system ensures optimum moisture control in production areas, testing & RD labs, clean rooms, hospitals, etc. and helps in maintaining hygienic conditions all year round, regardless of the ambient conditions, at a very low dew point.

Bry-Air is the fastest-growing adsorption technology in the world. We aim to reduce energy consumption and conserve energy for future purposes. Our objective is to focus on sustainable development, and with the help of our various patented energy smart technologies, we provide dehumidifiers and other latest solution offerings to manufacturers for their varied and complex quality air requirements. For more information, visit www.bryair.com

 

  • Bry Air newsletter pahwa_logo
  • bryair_logo
  • DRI Logo
  • Delair Logo
  • Bry Air tds_logo
  • accentium logo
×

BryCare Support

×
Top